Yoneyama T - Search Results

1

Treatment patterns and prognosis in patients with Bacillus Calmette-Guérin-exposed high-risk non-muscle invasive bladder cancer: a real-world data analysis.

Nishimura N, Miyake M, Iida K, Miyamoto T, Tomida R, Numakura K, Inokuchi J, Yoneyama T, Okajima E, Yajima S, Masuda H, Terada N, Taoka R, Kobayashi T, Kojima T, Matsui Y, Nishiyama N, Kitamura H, Nishiyama H, Fujimoto K. Nishimura N, et al. Among authors: yoneyama t. World J Urol. 2024 Mar 21;42(1):185. doi: 10.1007/s00345-024-04834-4. World J Urol. 2024. PMID: 38512511

2

Low-dose instillation therapy with bacille Calmette-Guérin Tokyo 172 strain after transurethral resection: historical cohort study.

Yoneyama T, Ohyama C, Imai A, Ishimura H, Hagisawa S, Iwabuchi I, Mori K, Kamimura N, Koie T, Yamato T, Suzuki T. Yoneyama T, et al. Urology. 2008 Jun;71(6):1161-5. doi: 10.1016/j.urology.2007.11.080. Epub 2008 Feb 15. Urology. 2008. PMID: 18279920

3

Uterus-, fallopian tube-, ovary-, and vagina-sparing cystectomy followed by U-shaped ileal neobladder construction for female bladder cancer patients: oncological and functional outcomes.

Koie T, Hatakeyama S, Yoneyama T, Hashimoto Y, Kamimura N, Ohyama C. Koie T, et al. Among authors: yoneyama t. Urology. 2010 Jun;75(6):1499-503. doi: 10.1016/j.urology.2009.08.083. Epub 2009 Dec 6. Urology. 2010. PMID: 19969331

4

Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.

Koie T, Ohyama C, Hosogoe S, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Mori K. Koie T, et al. Among authors: yoneyama t. Int Urol Nephrol. 2015 Sep;47(9):1509-14. doi: 10.1007/s11255-015-1048-3. Epub 2015 Jul 7. Int Urol Nephrol. 2015. PMID: 26149637

5

Essential content of evidence-based clinical practice guidelines for bladder cancer: The Japanese Urological Association 2015 update.

Kubota Y, Nakaigawa N; Committee for Establishment of the Clinical Practice Guideline for the Management of Bladder Cancer and the Japanese Urological Association. Kubota Y, et al. Int J Urol. 2016 Aug;23(8):640-5. doi: 10.1111/iju.13141. Epub 2016 Jul 3. Int J Urol. 2016. PMID: 27374472

6

Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis.

Konishi S, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Fujita N, Ishibashi Y, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C. Konishi S, et al. Among authors: yoneyama t. Med Oncol. 2018 Nov 24;36(1):6. doi: 10.1007/s12032-018-1231-3. Med Oncol. 2018. PMID: 30474747

7

Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma.

Okita K, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Fujita N, Ishibashi Y, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C. Okita K, et al. Among authors: yoneyama t. Clin Genitourin Cancer. 2019 Jun;17(3):e440-e446. doi: 10.1016/j.clgc.2019.01.006. Epub 2019 Jan 17. Clin Genitourin Cancer. 2019. PMID: 30772204

8

C-reactive protein/albumin ratio is a predictive factor for prognosis in patients with metastatic renal cell carcinoma.

Konishi S, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Hamano I, Fujita N, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C. Konishi S, et al. Among authors: yoneyama t. Int J Urol. 2019 Oct;26(10):992-998. doi: 10.1111/iju.14078. Epub 2019 Jul 24. Int J Urol. 2019. PMID: 31342557

9

Validation of the IMDC Prognostic Model in Patients With Metastatic Renal-Cell Carcinoma Treated With First-Line Axitinib: A Multicenter Retrospective Study.

Konishi S, Hatakeyama S, Numakura K, Narita S, Inoue T, Saito M, Tokui N, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Narita S, Kawaguchi T, Habuchi T, Ohyama C. Konishi S, et al. Among authors: yoneyama t. Clin Genitourin Cancer. 2019 Oct;17(5):e1080-e1089. doi: 10.1016/j.clgc.2019.07.006. Epub 2019 Jul 20. Clin Genitourin Cancer. 2019. PMID: 31416753

10

The association between serum serotonin levels and overactive bladder: results from a community-based cross-sectional study in Japan.

Okamoto T, Hatakeyama S, Imai A, Yamamoto H, Yoneyama T, Mori K, Yoneyama T, Hashimoto Y, Nakaji S, Ohyama C. Okamoto T, et al. Among authors: yoneyama t. World J Urol. 2021 Jan;39(1):169-175. doi: 10.1007/s00345-020-03167-2. Epub 2020 Mar 19. World J Urol. 2021. PMID: 32193653

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

896 results

Search Page